Sign in

CIK 0001367083

  • Non-accelerated filer
  • Smaller reporting company

Sonoma Pharmaceuticals, Inc.

Sign in to watch
Ticker
SNOA
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
680423298
Phone
+1 800-759-9305
Business address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
Former names
Oculus Innovative Sciences, Inc.
  1. 4 Grant or award Exe. VP of Research and Dev. acquired 3,404 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 4,124 shares (grant or award)
  3. 4 Grant or award Director acquired 1,036 shares (grant or award)
  4. 4 Grant or award Director acquired 895 shares (grant or award)
  5. 4 Grant or award Director acquired 612 shares (grant or award)
  6. 4 Grant or award Director acquired 754 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Chief Financial Officer bought 750 shares at an average $7.02 ($5,268)
  12. 4 Open-market buy Chief Financial Officer bought 1,000 shares at an average $6.93 ($6,930)
  13. 4 Open-market buy Chief Strategy/Mkt Officer bought 750 shares at $6.82 ($5,115)
  14. 4 Open-market buy Chief Executive Officer bought 800 shares at an average $6.78 ($5,421)
  15. 4 Grant or award Director acquired 3,226 shares (grant or award)
  16. 4 Grant or award Director acquired 3,093 shares (grant or award)
  17. 4 Grant or award Director acquired 2,827 shares (grant or award)
  18. 4 Grant or award Director acquired 2,960 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 6 of 16 · 317 filings